Tuesday, September 05, 2017 4:09:35 PM
Nobody was posting over here,and I can`t stand the YMB. This is better,so lets keep this going. I know we sold the Premie app for Iplex to shire for 11 million,but some people are confused,including myself as to what apps for Iplex we sold,if any other than for Premies,and what we still have that`s ours for Iplex. I bought this company because of iplex,,Arikace became an incredible acquisition but I definitely want to know the companies plans for Iplex. If there`s none,the stock won`t negatively react because they treated Iplex like it`s a dead dog for years and years,and if they do announce it`s alive and well,and they have plans for it,IMO,we see a big jump..
Recent INSM News
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/13/2026 09:24:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/13/2026 09:18:59 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/13/2026 09:17:49 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/13/2026 09:17:24 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/13/2026 09:14:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2026 08:50:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/11/2026 08:46:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 11:01:37 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 11:00:34 AM
- Insmed Reports First-Quarter 2026 Financial Results and Provides Business Update • PR Newswire (US) • 05/07/2026 11:00:00 AM
- Insmed and Ty Pennington Team Up to Drive Awareness and Proper Diagnosis of Bronchiectasis • PR Newswire (US) • 05/06/2026 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2026 08:11:30 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/04/2026 08:55:19 PM
- Insmed to Present Data Across Its Respiratory Portfolio, Including Late-Breaking ARIKAYCE® Results from Phase 3b ENCORE Study, at the American Thoracic Society International Conference 2026 • PR Newswire (US) • 05/04/2026 11:00:00 AM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/30/2026 02:37:43 PM
- Insmed to Present at May 2026 Investor Conferences • PR Newswire (US) • 04/30/2026 11:00:00 AM
- Insmed to Host First-Quarter 2026 Financial Results Conference Call on Thursday, May 7, 2026 • PR Newswire (US) • 04/23/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 08:43:36 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/16/2026 08:17:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2026 08:41:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 08:01:21 PM
- Insmed Provides Clinical Update on Phase 2b CEDAR Study • PR Newswire (US) • 04/07/2026 08:01:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/06/2026 08:42:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 08:07:37 PM
